The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2018
https://researcherprofiles.org/profile/17491620
29917079